Zhongshan Hospital, formerly Chung Shan Memorial Hospital, is a major teaching hospital in Shanghai, China, affiliated with the Shanghai Medical College of Fudan University.

During the past decade, Zhongshan Hospital, Fudan University conducted 500 clinical trials. In the 10-year time frame, 500 clinical trials started and 48 clinical trials were completed, i.e. on average, 9.6% percent of trials that started reached the finish line to date. In the past 5 years, 284 clinical trials started and 38 clinical trials were completed. i.e. 13.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Zhongshan Hospital, Fudan University" #1 sponsor was "Shanghai Zhongshan Hospital" with 157 trials, followed by "Fudan University" with 42 trials sponsored, "Hoffmann-La Roche" with 31 trials sponsored, "Boehringer Ingelheim" with 12 trials sponsored and "BeiGene" with 12 trials sponsored. Other sponsors include 347 different institutions and companies that sponsored additional 192 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Zhongshan Hospital, Fudan University" #1 collaborator was "Shanghai Zhongshan Hospital" with 46 trials as a collaborator, "Fudan University" with 27 trials as a collaborator, "Ruijin Hospital" with 19 trials as a collaborator, "RenJi Hospital" with 16 trials as a collaborator and "Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine" with 15 trials as a collaborator. Other collaborators include 622 different institutions and companies that were collaborators in the rest 320 trials.

According to Clinical.Site data, the most researched conditions in "Zhongshan Hospital, Fudan University" are "Hepatocellular Carcinoma" (35 trials), "Gastric Cancer" (19 trials), "Coronary Artery Disease" (18 trials), "Colorectal Cancer" (15 trials) and "Colorectal Neoplasms" (10 trials). Many other conditions were trialed in "Zhongshan Hospital, Fudan University" in a lesser frequency.

Most popular intervention types in "Zhongshan Hospital, Fudan University" are "Drug" (359 trials), "Device" (92 trials), "Procedure" (84 trials), "Other" (49 trials) and "Biological" (22 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (61 trials), "Atezolizumab" (21 trials), "Cisplatin" (17 trials), "placebo" (11 trials) and "Tislelizumab" (10 trials). Other intervention names were less common.

The vast majority of trials in "Zhongshan Hospital, Fudan University" are 573 trials for "All" genders, 17 trials for "Female" genders and 14 trials for "Male" genders.

Currently, there are 265 active trials in "Zhongshan Hospital, Fudan University". 21 are not yet recruiting, 177 are recruiting, 62 are Active, not recruiting, and 5 are Enrolling by invitation. In total, there were 158 completed trials in Zhongshan Hospital, Fudan University, 2 suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Zhongshan Hospital, Fudan University, 46 "Phase 1" clinical trials were conducted, 115 "Phase 2" clinical trials and 169 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 66 trials, and there were also 129 trials that are defined as “Not Applicable".